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ABSTRACT
Cervical cancer is the fourth most common cancer in women worldwide with
human papillomavirus (HPV) being the main cause the disease. Chromosomal
ampliﬁcations have been identiﬁed as a source of upregulation for cervical cancer
driver genes but cannot fully explain increased expression of immune genes in
invasive carcinoma. Insight into additional factors that may tip the balance from
immune tolerance of HPV to the elimination of the virus may lead to better
diagnosis markers. We investigated whether microbiota affect molecular pathways
in cervical carcinogenesis by performing microbiome analysis via sequencing 16S
rRNA in tumor biopsies from 121 patients. While we detected a large number of
intra-tumor taxa (289 operational taxonomic units (OTUs)), we focused on the 38
most abundantly represented microbes. To search for microbes and host genes
potentially involved in the interaction, we reconstructed a transkingdom network
by integrating a previously discovered cervical cancer gene expression network with
our bacterial co-abundance network and employed bipartite betweenness
centrality. The top ranked microbes were represented by the families Bacillaceae,
Halobacteriaceae, and Prevotellaceae. While we could not deﬁne the ﬁrst two
families to the species level, Prevotellaceae was assigned to Prevotella bivia. By co-
culturing a cervical cancer cell line with P. bivia, we conﬁrmed that three out of the
ten top predicted genes in the transkingdom network (lysosomal associated
membrane protein 3 (LAMP3), STAT1, TAP1), all regulators of immunological
pathways, were upregulated by this microorganism. Therefore, we propose that
intra-tumor microbiota may contribute to cervical carcinogenesis through the
induction of immune response drivers, including the well-known cancer gene
LAMP3.
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INTRODUCTION
Cervical cancer remains the fourth most common cancer in women worldwide, and
the world’s second highest cause of female cancer mortality (Ginsburg et al., 2017).
Persistent infection with high-risk human papillomavirus (hrHPV) is a causative factor
in cervical carcinogenesis (Walboomers et al., 1999). The HPV vaccination is expected
to decrease the cancer incidence, however, in Central and Eastern Europe and developing
countries where there is a lack of systematic screening and vaccination programs,
morbidity and mortality are anticipated to remain high. Thus, cervical carcinogenesis
will remain a major threat to women’s health. Most women who are infected with HPV
never develop cancer. Hence, persistent HPV infection is necessary but may not be
sufﬁcient to trigger cancer development. A better understanding of the additional
factors required for carcinogenesis would improve identiﬁcation of high-risk cases
and represents a major step toward personalized medicine in cervical cancer (Shulzhenko
et al., 2014).
According to the current model of cervical carcinogenesis, hrHPV exists in the
episomal state within basal cells in the epithelium during early disease onset (Munoz
et al., 2006). The viral gene E2, while expressed, suppresses expression of E6 and E7
viral oncogenes. The longer the infection persists, the more HPV integrates into the host
genome. Upon integration, the open reading frame of E2 is disrupted which reduces
the control of E6 and E7 and promotes cell proliferation (Shulzhenko et al., 2014).
Therefore, the key event that turns chronic HPV infection into cancer is elimination of
the episomal form of virus as it is the only source of the oncosuppressor E2. The host
immune system may eliminate episomal HPV, giving the cells with an integrated form of
virus a growth advantage (Herdman et al., 2006). Although insufﬁcient antiviral immunity
enables persistent HPV infection at an early state, proceeding to the integrated state seems
to require activation of the woman’s immune system. Chromosomal ampliﬁcations in the
infected cells have recently been identiﬁed as one of the key sources of driver genes
upregulation in this disease (Mine et al., 2013). However, these genomic alterations cannot
fully explain increased expression of immune genes in invasive carcinoma. Additional
factors that may tip the balance from making the immune system tolerate HPV to
eliminate virus are so far unknown.
Microbiota can have a signiﬁcant role in disease, contributing to development of
metabolic (diabetes, enteropathy associated with common variable immunodeﬁciency,
etc.) and immune (inﬂammatory bowel disease, asthma, allergy) disorders as well as cancer
(colorectal, gastric, lung, pancreatic etc.) (Ege et al., 2011; Farrell et al., 2012; Fujimura &
Lynch, 2015; Geng et al., 2013; Greer et al., 2016; Hosgood et al., 2014; Knights,
Lassen & Xavier, 2013;Marchesi et al., 2011; Shulzhenko et al., 2017; Stokholm et al., 2018;
Uemura et al., 2001). Microbial communities have also been found to speciﬁcally
contribute to virus induced carcinogenesis (Vyshenska et al., 2017). In particular, multiple
studies conﬁrm vaginal dysbiosis (bacterial vaginosis) to be a risk factor for HPV infection
(Gillet et al., 2011) and its progression (Gillet et al., 2012; Oh et al., 2015). Studies of
vaginal (Champer et al., 2017) and cervical (Vyshenska et al., 2017) microbiota have found
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associations between changes in microbial community (e.g., overall diversity,
abundances of particular taxa) and cancer development. Furthermore, the location of
this cancer suggests a possible role of common members of cervico-vaginal microbiota in
cervical carcinogenesis. While almost 25 years ago, bacteria cultured from cervical cancer
biopsies were proposed to contribute to cancer progression, we are still far from
understanding the role of non-viral microbes in this disease (Mikamo et al., 1993).
In this study, we aimed to investigate whether microbiota may affect molecular
pathways in cervical carcinogenesis. We reconstructed a transkingdom network that
integrates microbiome and host transcriptome data in tumor samples from patients to
infer key bacterial players. We demonstrate the signiﬁcance of this approach by identifying
several bacterial candidates and show that one of them (Prevotella bivia) upregulates a
well-known human cancer driver, lysosomal associated membrane protein 3 (LAMP3).
MATERIALS AND METHODS
Patients
Tumor specimens were retrieved from 123 patients with locally advanced squamous cell
carcinoma of the uterine cervix. One to four biopsies were taken at different locations
of the tumor at the time of diagnosis, immediately frozen in liquid nitrogen, and stored
at -80 C. DNA and RNA from different biopsies of the same tumor were pooled.
The clinical protocol was approved by the Regional Committee for Medical Research
Ethics in southern Norway (REC no. S-01129). Written informed consent was obtained
from all patients (Form S1). DNA was isolated according to a standard protocol with
proteinase K, phenol, chloroform, and isoamylalcohol (De Angelis et al., 1999).
Puriﬁed DNA quality and concentration were assessed using the Quant-iTTM PicoGreen
dsDNA Assay Kit (Life Technologies, Carlsbad, CA, USA).
Gene expression
Gene expression proﬁling of 123 tumors used in this study was performed using the
Illumina HumanWG-6 v3 Expression BeadArrays with approximately 48,000 transcripts
(Illumina Inc., San Diego, CA, USA). All samples had more than 50% tumor cells in
hematoxylin and eosin stained sections. This selection may have led to some bias in the
results, but was chosen to reduce the inﬂuence of different normal cell proportion across
the samples. Total RNA was isolated by the use of Trizol reagent (Life Technologies,
Carlsbad, CA, USA) followed by LiCl precipitation. Hybridization, scanning, signal
extraction, and normalization were performed as described (Lando et al., 2009).
Bacterial DNA quantification
Bacterial content was quantiﬁed using QuantiFast SYBR Green mix (Qiagen,
Germantown, MD, USA) and universal bacterial primers, UniF340 (5′-ACTCCTACGGG
AGGCAGCAGT) and UniR514 (5′-ATTACCGCGGCTGCTGGC). Standards were
created from serial dilutions of extracted DNA from bacteria grown from mouse
cecum contents.
Lam et al. (2018), PeerJ, DOI 10.7717/peerj.5590 3/21
16S rRNA library preparation and sequencing
For MiSeq Illumina sequencing, total genomic DNA was subjected to PCR ampliﬁcation
targeting the 16S rRNA variable region 4 (v4) using the bacterial primers 515F/806R.
Test reactions were performed with samples with varying amounts of bacterial DNA to
determine the threshold for successful library preparation, deﬁned as a positive band on
an agarose gel. A total of 40–250 ng of total template DNA were used for each PCR
reaction, performed in triplicates per sample. Each set of triplicate PCR reactions was
pooled and puriﬁed using the MinElute PCR Puriﬁcation Kit (Qiagen, Germantown, MD,
USA). The pools were checked for proper band size of 382 bp by gel electrophoresis using
2% agarose pre-cast E-gels (Life Technologies, Carlsbad, CA, USA). Negative controls
consisted of samples without template for DNA extraction and PCR ampliﬁcation.
The pools were then quantiﬁed using the Qubit dsDNA BR Assay Kit (Life Technologies,
Carlsbad, CA, USA). Barcoded amplicons were pooled at equal volumes and
concentrations (two mL of ﬁve ng/mL DNA). The total pool was sequenced using the
Illumina MiSeq 2000 sequencing platform at the Center for Genome Research and
Biocomputing at Oregon State University to generate pair-ended 250 nt reads. The dataset
generated and analyzed during the current study is available in Sequence Read Archive
under accession no. SRP131188.
Processing of raw 16S rRNA reads
Raw forward-end FASTQ reads from the Illumina sequencing output were quality ﬁltered,
demultiplexed, and analyzed using quantitative insights into microbial ecology (QIIME)
(Caporaso et al., 2010). Reads were quality ﬁltered using default QIIME parameters;
reads with a Phred quality score of <20, ambiguous base calls, and fewer than 187 nt
(75% of 250 nt) of consecutive high-quality base calls were discarded. Additionally,
truncation occurred on reads with three consecutive low-quality bases. The samples
were demultiplexed using 12 bp barcodes, allowing for a maximum of 1.5 errors in the
barcode.
Reads were clustered using UCLUST (Edgar, 2010) at 97% similarity into
operational taxonomic units (OTUs) at QIIME default parameters. A representative
set of sequences from each OTU were selected for taxonomic identiﬁcation by selecting
the cluster seeds (ﬁrst read assigned to that OTU). Representative sequences for each
OTU were aligned using BLAST (e-value < 0.001) to Greengenes (version 13.8) OTU
reference sequences (97% similarity) to obtain taxonomy assignments. OTUs were
ﬁltered for singletons (only found in one sample) and relative abundance was quantiﬁed
by dividing raw read counts by total number of reads for each sample. Alpha diversity
rarefaction curves using the Shannon index and a heatmap of OTU frequencies were
obtained from QIIME scripts using default parameters.
Comparing bacterial communities from different body sites
Human microbiome project data
High-quality FASTQ reads for region v3 and v5 were obtained
(ftp://public-ftp.ihmpdcc.org/HMQCP/seqs_v35.fna.gz). Female patients from the
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ﬁrst visit were retained if they had samples from vagina (posterior_fornix) and at least
stool or skin (left and right of antecubital fossa and retroauricular crease) to allow
multi-site comparisons for the same patient. In case there were multiple samples from
the same site of a patient, we retained the sample with highest number of sequences
assigned to OTUs. This resulted a total of 380 samples from 77 females.
Healthy cervix
Raw FASTQ data for 17 HPV negative samples was obtained from European Nucleotide
Archive, Study PRJEB1872, and used as healthy cervix samples. High-quality reads
(Phred score >19) were retained using QIIME’s split_libraries_fastq.py command and a
Phred offset of 33.
To allow comparisons between studies, reads for the 455 samples (Table S2) were
assigned to OTUs at 97% sequence similarity using UCLUST and closed reference
OTU picking. The reverse strand match was enabled for the human microbiome project
(HMP) data during OTU picking. The studies were merged using common OTU IDs.
Singleton OTUs were removed. The combined OTU table had 455 samples and 2,516,046
sequences assigned to 444 OTUs (Table S2). The table was rareﬁed with a sequence
threshold of 1,000 sequences (Table S2) and used for diversity analysis. Beta diversity was
calculated using weighted and unweighted unifrac and used for PCoA analysis. Alpha
diversities were compared using Shannon diversity index.
Cervical cancer samples with greater than 1,000 sequences (based on the above
threshold used for rarefaction) assigned to OTUs were retained and singleton OTUs were
removed. The resulting OTU table had 432 OTUs for 52 cervical cancer samples
(Table S2), was relativized and used to create a heat tree at the genus level using Metacoder
(Foster, Sharpton & Grunwald, 2017).
OTU collapsing
An initial quality check of de novo cervical cancer OTUs were made against healthy
vaginal samples from the HMP (as described below). OTU representative sequences,
OTU table, and mapping ﬁle for 16S rRNA v3–v5 sequencing were downloaded from the
HMP QIIME community proﬁling datasets publicly available (The Human Microbiome
Project Consortium, 2012b). Representative sequences from cervical cancer de novo
picked OTUs were aligned to HMP representative sequences using USEARCH. Sequences
with identity matches greater than 0.97 were collapsed together, keeping HMP OTU
identiﬁcation, taxonomy, and representative sequences as appropriate; if multiple cervical
cancer OTUs matched, their read counts were summed for each sample. These new
“collapsed” OTUs were used for subsequent analyses.
Transkingdom network reconstruction
Pairwise Spearman correlations were calculated for each OTU with mean relative
abundance >0.5%. Spearman correlations were additionally calculated between top OTUs
and 738 differentially expressed genes (DEGs) (quantile-normalized gene expression
microarray, raw data available in Gene Expression Omnibus under accession no.
GSE68339) found in previous cancer gene regulatory network (Mine et al., 2013).
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Correlations with p < 0.001 and FDR < 0.1 were imported into igraph R package for
network reconstruction. Gene-OTU correlations were integrated with OTU–OTU
correlations along with the previously published gene–gene network. Multiple edges and
self-loops were removed. Visualization was performed in Cytoscape.
Bipartite betweenness centrality (BiBC) is the measure of probability for nodes
belonging to one subnetwork to be bottlenecks in the transfer of signal to the nodes in
another subnetwork, and vice versa. It was calculated as previously described (Dong
et al., 2015) between the microbial subnetwork and each DEG subnetwork as well as all
DEGs. Relativized BiBC values were calculated by dividing the value of a particular
node to the sum of all nodes in that metric. Relativized BiBC values were then log
transformed as followed:
log2 BiBC  106 þ 1 
Prevotella OTU alignment
Representative sequences were extracted for all original cancer de novo OTUs that were
collapsed into OTU_97.1949. These sequences were aligned to SILVA 16S rRNA
sequences for Prevotella using USEARCH. Matches with length >200 bp and mismatch
40 bp were kept for quantiﬁcations. For each species, the numbers of hits for each
representative sequence were summed after normalization to the total number of hits
for that representative sequence. This method was used due to multiple database matches
for each given representative sequence due to high similarity and low speciﬁcity of the
query sequence.
Human cell culture
HeLa cervical cancer cell line was acquired from ATCC and maintained in modiﬁed
Eagle’s medium (EMEM) with Earle’s balanced salt solution, L-glutamine, and non-
essential amino acids, without Calcium. EMEM was supplemented with 5% heat-
inactivated fetal bovine serum and 1% penicillin streptomycin solution (PEST). Frozen
cells stored in 10% DMSO in liquid nitrogen were thawed in a 37 C water bath until
thawed (∼3 min), added to four mL of fresh media, and centrifuged for 3 min at 2,500 rpm
to pellet cells. The media solution was aspirated, and cells were resuspended in 15 mL
of fresh media. Cells were grown in 5% CO2 at 37 C in 75 cm
2 treated, vented cap
ﬂat bottom culture ﬂasks. Cells were passaged at approximately 80% conﬂuency using
three mL of 0.25% Trypsin supplemented with 2.21 mM EDTA without sodium
bicarbonate to detach adherent cells.
Bacteria cell culture
The following bacteria were used in this study: P. bivia (ATCC 29303) and Lactobacillus
crispatus (ATCC 33197). All bacteria were grown on Brucella blood agar plates
supplemented with hemin and vitamin K (Hardy Diagnostics, Santa Maria, CA, USA) at
37 C in anaerobic conditions using the GasPakTM EZ Container System (BD Diagnostics,
Sparks, MD, USA). Cultures were stored in 25% glycerol at -80 C. Bacterial plates
were restreaked once every 2–3 days as needed for experiments.
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Human-bacteria co-culture
Bacterial cultures were taken from frozen stocks, plated on Brucella blood agar plates,
and restreaked after 3 days. After incubation for 2 days, bacteria were suspended in
three mL of PBS and quantiﬁed by optical density at OD600 nm; correlations between
OD600 and colony forming units were made prior to the experiments. HeLa cells were
resuspended in EMEM media without PEST, counted using a hemocytometer, seeded
at 75,000 cells/well in 24-well ﬂat bottom culture plates, and incubated at 37 C in 5% CO2
24 h prior to bacterial treatment. Bacteria were adjusted to appropriate concentration
for 40 mL treatments at a multiplicity of infection of 10 in replicates of three or more,
using sterile PBS as the negative control. Bacteria-treated HeLa cells were incubated at
37 C in anaerobic conditions using GasPakTM EZ Anaerobe Container System Sachets for
either 24 h, followed by on-plate lysis using RLT Lysis Buffer (Qiagen, Germantown,
MD, USA) and lysate storage at -80 C.
RT-quantitative PCR for co-culture experiment
RNA was extracted from cell lysate using the RNeasy Mini Kit (Qiagen, Germantown, MD,
USA) with on-column DNase digestion. RNA was quantiﬁed using Qubit RNA BR
Assay Kit (Life Technologies, Carlsbad, CA, USA) and reverse transcribed using qScript
cDNA Synthesis Kit (Quantabio, Beverly, MA, USA). RT-quantitative PCR (qPCR)
was performed using PerfeCTA SYBR Green FastMix (Quantabio, Beverly, MA, USA)
and human gene primers (Table S5). RT-qPCR set up was as follows: sample was heated
to 95 C, followed by 40 cycles of 95 C for 10 s and 60 C for 30 s. Fold change was
calculated by normalizing to 18S rRNA housekeeping gene.
RESULTS
Varying amounts of bacterial DNA were detected by qPCR in 121 out of 123 tumor
samples from cervical cancer patients (Table S1). Sufﬁcient amounts for 16S rRNA library
preparation and sequencing was found in 58 samples. After 16S rRNA sequencing and
quality ﬁltering, we obtained 3,975,755 high-quality reads with a median of 87,320
reads/sample.
As a ﬁrst step of analysis, we evaluated our cancer microbiome data in relation to
publicly available datasets for adjacent healthy body sites (Audirac-Chalifour et al., 2016;
Di Paola et al., 2017; Gajer et al., 2012; Hong et al., 2016; Lee et al., 2013; Ling et al., 2010;
Liu et al., 2013; Ravel et al., 2011; Si et al., 2017) and sites sampled by the HMP
(The Human Microbiome Project Consortium, 2012a, 2012b). While such analysis is
limited since the samples were not matched (i.e., not the same individuals), it provides
general information about the microbiota in cervical cancer compared to other tissues.
Unsupervised principal coordinate analysis using common OTUs showed that the
cervical cancer samples had a different microbiome composition than samples from healthy
cervix, vagina, stool, or skin samples (Fig. 1A). Compared to healthy uterine cervix and
vagina, the cancer microbiome showed increased alpha diversity (Fig. S1) and high
abundance of genera such as Prevotella (27.3%), Fusobacterium (17%), and Peptoniphilus
(10.8%) as well as a low abundance of Lactobacillus (0.5%) (Figs. 1B and 1C and Table S2).
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Figure 1 Community composition in cervical cancer and healthy adjacent sites. (A) PCoA of
unweighted unifrac comparing microbiota of samples from cervical cancer (n = 52), healthy cervix
(n = 17), vagina (n = 76), stool (n = 28), and skin (n = 55). (B) Bar chart of mean relative abundance of
genera in cervical cancer biopsies, cytobrush from healthy ectocervical mucosa, and swab from healthy
posterior vaginal fornix. Genera are arranged in descending order of mean relative abundance in cervical
cancer samples from bottom to top of the bar chart. Genera with mean relative abundance <0.5% across
the three sites are grouped into “Other” found at bottom of bar chart. (C) Phylogenetic tree indicating the
relationship and mean relative abundance (blue color intensity) of various genera in cervical cancer
samples. The size of node and its label indicate the number of OTUs belonging to that taxonomy.
Full-size DOI: 10.7717/peerj.5590/ﬁg-1
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To investigate whether the bacteria inﬂuence molecular pathways in the tumors,
we built a transkingdom network that integrated microbial abundance and cancer gene
expression networks. First, OTUs with an abundance of at least 0.5% were selected,
and a bacterial co-abundance network that contained 38 nodes and 54 edges was
reconstructed. For the human portion of the transkingdom network, we selected the
network based on meta-analysis of transcriptomes from ﬁve cohorts of cervical cancer
patients (Shulzhenko et al., 2014). In that study, we reconstructed a gene expression
meta-network, identifying three pathways with upregulated cell cycle and
proinﬂammatory/antiviral genes, and downregulated epithelial cell differentiation genes
as key features of cervical carcinogenesis. To integrate the microbial and human
subnetworks we calculated correlations between microbial abundances and gene
expression from the cancer network measured in the same tumor samples as bacteria.
The network contained 21 taxa and 698 human genes connected by 19 transkingdom edges
(Fig. 2A).
The inﬂammatory/antiviral genes are the most plausible targets of regulation by
bacteria. In addition, antiviral gene expression is of special interest in cervical cancer due to
its involvement in elimination of episomal HPV that leads to tumor growth (Pett et al.,
2006; Vyshenska et al., 2017). Therefore, to infer bacteria that may drive changes in cancer
gene expression we searched for “bottleneck” bacterial nodes that link microbial and
inﬂammatory/antiviral subnetworks using the BiBC metric (Dong et al., 2015; Morgun
et al., 2015; Thomas et al., 2016). The top three microbes with highest BiBC represented
OTUs from families Bacillaceae and Halobacteriaceae and the genus Prevotella (Fig. 2B).
Due to limitations of 16S rRNA sequencing (limited resolution and sensitivity if
compared to metagenomic data analysis (Poretsky et al., 2014)), QIIME was unable to
assign these OTUs to speciﬁc species. However, the Prevotella OTU had more advanced
assignment than the other two top OTUs, which were assigned only to family level.
An alternative bioinformatics approach was therefore used to identify bacterial species that
were represented by the Prevotella-related OTU. We aligned representative sequences
from all OTUs that were collapsed into the Prevotella OTU (OTU_97.1949) to the
SILVA 16S rRNA database containing sequences of Prevotella genus (Fig. 2C).
While matches for seven different species from this genus were found, P. bivia had the
most hits, indicating that this species was the most probable bacterium connected to
cancer gene expression. Review of recent literature with publicly available 16S rRNA data
of healthy cervix and vagina showed that Prevotella had much higher abundance in
our cervical cancer cohort than in ﬁve studies of healthy vagina (Gajer et al., 2012;
Hong et al., 2016; Ling et al., 2010; Liu et al., 2013; Ravel et al., 2011) and four studies
of healthy cervix (Audirac-Chalifour et al., 2016; Di Paola et al., 2017; Lee et al., 2013;
Si et al., 2017) (Fig. 2D and Table S4). Altogether these results provided P. bivia as a
candidate bacterium that may contribute to upregulation of proinﬂammatory/antiviral
genes in cervical cancer.
Cervical carcinomas consist of a mixture of stromal, immune, and cancer cells
(Pilch et al., 2001; Sheu et al., 2001). Therefore, the bacteria harbored by tumor might
have direct and indirect effects on cancer cells. To test if bacteria predicted by our analysis
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Figure 2 Transkingdom microbe-gene regulatory network. (A) Transkingdom correlation network
(p < 0.001; FDR < 0.1) between microbial network (21 OTUs, 50 edges) and previously described
(Mine et al., 2013) tumor differentially expressed genes (698 DEGs, 3,066 edges) connected by 19 edges.
Edge-weighted spring layout was performed in Cytoscape. Nodes represent: orange—bacteria; green—
antiviral genes; purple—epithelial cell differentiation genes; blue—cell cycle genes; and gray—genes not
assigned to speciﬁc subnetwork or function. Lines indicate: blue—positive of correlation between nodes;
red—negative of correlation between nodes. Orange star indicates Prevotella OTU with high BiBC
whereas dashed lines connecting the node and its name designate the top ﬁve BiBC scored bacteria OTU.
(B) Top BiBC OTUs (15/38) calculated between microbial subnetwork and antiviral subnetwork. (C) Top
Prevotella species in SILVA 16S rRNA database matched to representative sequences assigned to
OTU_97.1949 (match length >200 bp, mismatch = 40 bp). (D) Prevotella mean abundance in cervical
cancer (CC) compared with previous 16S studies for healthy adjacent sites: HPV negative cervix
(HPV-cervix) and healthy vaginal microbiome (healthy vagina). (PMID numbers of the source article
speciﬁed for each column). Full-size DOI: 10.7717/peerj.5590/ﬁg-2
Figure 3 Host gene expression regulated by P. bivia. (A) Top DEGs (60/738) ranked by BiBC centrality
calculated between bacteria and antiviral genes in transkingdom network (normalized BiBC = log2
((BiBC106) + 1)). (B–D) RT-qPCR for cervical cancer top BiBC genes (LAMP3, STAT1, and TAP1), for
which gene expression was upregulated in HeLa cells by P. bivia but not L. crispatus co-culture compared
to negative treatment (PBS). mRNA levels were normalized to 18S rRNA gene expression. (p-value <
0.05, one-tailed Wilcoxon matched-pairs signed rank test). Full-size DOI: 10.7717/peerj.5590/ﬁg-3
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can drive cervical cancer gene expression program directly, we performed in vitro
co-incubation of P. bivia with a cervical cancer cell line (HeLa) and measured expression
of selected genes. We used L. crispatus as a control because it is a common standard in
co-culture studies for bacterial induction of innate immunity (Eade et al., 2012;
Libby et al., 2008). While L. crispatus was among top most abundant bacteria detected
in cancer samples, it showed decreased abundance in cervical cancer compared to other
body sights (Fig. S2 and Table S4) and it was not connected to any cancer genes in the
transkingdom network (BiBC = 0) indicating no inﬂuence on cancer gene expression
program. To evaluate which genes might be the most affected by bacteria we
calculated BiBC between the microbial portion of the transkingdom network and
inﬂammatory/antiviral subnetwork and selected top 10 genes for further analysis (Fig. 3A).
Our gene expression data was generated from whole tissue samples; therefore, it was
not surprising that two (GZMB, CXCL10) out of 10 selected genes were not detected
in the co-incubation experiments with the cancer cell line. Indeed, GZMB is mostly
expressed by T-lymphocytes and natural killer cells (Bratke et al., 2005; Johnson et al.,
2003) and probable sources of CXCL10 expression are endothelial and stromal cells
(Panzer et al., 2006; Proost et al., 2003). Among the eight remaining genes we found that
three (LAMP3, STAT1, and TAP1) were upregulated by P. bivia (Figs. 3B–3D) whereas no
genes were downregulated by this bacterium (Figs. 3B–3D and Fig. S3). These results
further support that intra-tumor bacteria like Prevotella may be involved in control of the
gene expression program of cervical cancer.
DISCUSSION
The use of transkingdom network analysis in our study provided novel insight into the
host-microbiome relationship in cervical cancer. The method has previously proved to be
successful for identiﬁcation of members of the microbial community responsible for a
variety of pathological situations, such as enteropathy associated with common variable
immunodeﬁciency (Shulzhenko et al., 2017), diabetes (Greer et al., 2016), as well as
microbes and microbial genes that regulate the effect of antibiotics on the intestine
(Morgun et al., 2015). Our work demonstrates a new approach where transkingdom
network is used to elucidate the pathogenic role of microbiota in cancer. We combined a
bacterial co-abundance network with gene expression of key pathways in cervical
carcinogenesis (Mine et al., 2013), increasing the probability of detecting host-microbiome
relationships of relevance for cancer development. The results strongly support a role
of microbes from the Bacillaceae and Halobacteriaceae families and the genus Prevotella
in regulation of a pro-inﬂammatory pathway that is activated in cervical cancer
(Mine et al., 2013). This opens the possibility that bacteria are involved in the elimination
of episomal HPV in cervical cancer and thereby play a role in carcinogenesis.
Results from the transkingdom network analysis were further tested and showed that
the most promising candidate, P. bivia, upregulated three genes (LAMP3, STAT1, and
TAP1) in the pro-inﬂammatory pathway (Mine et al., 2013). Noteworthy, LAMP3 is one of
the key drivers of this pathway that controls expression of STAT1 and several other
antiviral genes (Mine et al., 2013). Overexpression of LAMP3 has been shown to promote
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metastasis in cervical cancer xenografts and to associate with poor treatment outcome
in clinical studies (Kanao et al., 2005). Moreover, LAMP3 is induced by hypoxic
conditions (Mujcic et al., 2009; Nagelkerke et al., 2013) and potentially stimulates hypoxia
dependent cancer metastasis (Lu & Kang, 2010; Nagelkerke et al., 2013). Co-culture of a
cervical cancer cell line with P. bivia in our work showed that this bacterium indeed
upregulates LAMP3 under anaerobic conditions. It is therefore reasonable to hypothesize
that P. bivia (and possibly anaerobes) attracted by hypoxic environment, inﬁltrates
the tumor and induces a pro-inﬂammatory gene expression program via up-regulation
of LAMP3. LAMP3 itself seems to play a crucial role in cervical cancer. Similarly to its
role in other cancer types (Nagelkerke et al., 2011; Sun et al., 2014), it promotes metastases
and, by driving expression of multiple antiviral genes, it is potentially involved in
elimination of episomal HPV which leads to overexpression of the E6 and E7 HPV
oncogenes and disease progression (Munger et al., 1989). To better understand the
mechanism of LAMP3 mediated effects in cervical cancer further studies are needed
that would use techniques of knockdown/knockout and overexpression of LAMP3 in
combination with P. bivia co-culture.
Our study is a ﬁrst step toward connecting intra-tumor microbiome to molecular
pathways operating in cervical cancer. We analyzed bulk gene expression of the tumor
containing a mixture of transcriptomes of different cell types. Therefore, it might not
be surprising that genes such as GZMB and CXCL10, which are expressed by
non-cancerous cells, were among top ones predicted to be induced by intra-tumor
microbiota. Therefore, future studies may take advantage of single cell sequencing
allowing for identiﬁcation of indirect communication between cancer cells and bacteria,
for example via inﬁltrating immune cells. In addition, while our results pointed to
several bacteria that might be important, we were able to focus only on one of them,
P. bivia. It is commonly believed that microbiota may affect its host through combined
effect of several taxa rather than as single bacterium (Lamont & Hajishengallis, 2015;
Round & Mazmanian, 2009). Better species identiﬁcation can be achieved by employing
shotgun together with 16S rRNA sequencing since this approach was shown to
improve detection and overall diversity of bacterial species (Dong et al., 2017; Ranjan et al.,
2016; Shulzhenko et al., 2017). Therefore, whole genome shotgun sequencing should be
considered in future studies.
CONCLUSIONS
A possible involvement of bacteria in the carcinogenesis of cervical cancer could have
implications for women presenting with persistent HPV infection. Unraveling the
crosstalk between cervico-vaginal microbiota and the woman body may allow
development of personalized preventative measures against the infection through
shaping the microbiome to favor fast virus elimination (Kassam et al., 2012). It could also
help to identify single bacterial or community markers of disease progression for better
diagnostics. When used together with HPV testing, such markers may lead to more
precise evaluation of a woman’s risk of developing cancer that would be especially
useful in undeveloped countries where access to the healthcare system is limited
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(Denny, Quinn & Sankaranarayanan, 2006). Additionally, new evidence points out to
cervical microbiome as an important player in development (Zhang et al., 2018a) and
treatment of cervical intraepithelial neoplasia (Zhang et al., 2018b) that needs to be
investigated and considered. Pinpointing the role of bacteria in treatment outcomes at
later stages of the disease (Iida et al., 2013; Muls et al., 2017; Vetizou et al., 2015) could
also empower identiﬁcation of bacterial and host gene targets for new anticancer therapies.
Our results open a new direction for the development of companion diagnostics that
would evaluate intra-tumor microbiome and guide the administration of antibiotics as
an adjuvant to standard therapy.
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